INFLUENCE OF INFLAMMATORY DISEASE ON THE CLINICAL PHARMACOKINETICS OF ATENOLOL AND METOPROLOL

被引：11

作者：

KIRCH, W

SPAHN, H

OHNHAUS, EE

KOHLER, H

HEINZ, U

MUTSCHLER, E

机构：

[1] UNIV FRANKFURT,INST PHARMACOL,D-6000 FRANKFURT 70,FED REP GER

[2] UNIV MAINZ,SCH MED,DEPT INTERNAL MED,D-6500 MAINZ,FED REP GER

来源：

BIOPHARMACEUTICS & DRUG DISPOSITION | 1983年 / 4卷 / 01期

关键词：

D O I：

10.1002/bdd.2510040110

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：73 / 81

页数：9

共 22 条

[1]

BARBER HE, 1977, BR J CLIN PHARM, V6, P446

[2] THE CLINICAL IMPORTANCE OF CARDIOSELECTIVITY AND LIPOPHILICITY IN BETA-BLOCKERS [J].

CRUICKSHANK, JM .

AMERICAN HEART JOURNAL, 1980, 100 (02) :160-178

[3]

DIESS W, 1976, AUST NZ J MED, V6, P365

[4] REDUCTION OF LIVER BLOOD-FLOW AND PROPRANOLOL METABOLISM BY CIMETIDINE [J].

FEELY, J ;

WILKINSON, GR ;

WOOD, AJJ .

NEW ENGLAND JOURNAL OF MEDICINE, 1981, 304 (12) :692-695

[5] INFLUENCE OF CIMETIDINE ON PHARMACOKINETICS OF PROPRANOLOL [J].

HEAGERTY, AM ;

DONOVAN, MA ;

CASTLEDEN, CM ;

POHL, JF ;

PATEL, L ;

HEDGES, A .

BRITISH MEDICAL JOURNAL, 1981, 282 (6280) :1917-1919

[6] EFFECTS OF INFLAMMATORY DISEASE ON PLASMA OXPRENOLOL CONCENTRATIONS [J].

KENDALL, MJ ;

QUARTERMAN, CP ;

BISHOP, H ;

SCHNEIDER, RE .

BRITISH MEDICAL JOURNAL, 1979, 2 (6188) :465-468

[7] PHARMACOKINETICS OF ATENOLOL IN RELATION TO RENAL-FUNCTION [J].

KIRCH, W ;

KOHLER, H ;

MUTSCHLER, E ;

SCHAFER, M .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 19 (01) :65-71

[8]

KIRCH W, 1981, LANCET, V2, P531

[9] INTERACTION OF ATENOLOL WITH FUROSEMIDE AND CALCIUM AND ALUMINUM SALTS [J].

KIRCH, W ;

SCHAFERKORTING, M ;

AXTHELM, T ;

KOHLER, H ;

MUTSCHLER, E .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 30 (04) :429-435

[10] ATENOLOL KINETICS IN RENAL-FAILURE [J].

MCAINSH, J ;

HOLMES, BF ;

SMITH, S ;

HOOD, D ;

WARREN, D .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 28 (03) :302-309

← 1 2 3 →